Minivelle Film, Extended Release
Product Images NDC 68968-6610

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Minivelle (NDC 68968-6610). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Noven Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Estradiol Usp (Minivelle Figure 1)

Estradiol Usp (Minivelle Figure 1)
FDA Label Image

Figure D (Minivelle Figure 10)

Figure D (Minivelle Figure 10)
FDA Label Image

Figures E And F (Minivelle Figure 11)

Figures E And F (Minivelle Figure 11)
FDA Label Image

Figure G (Minivelle Figure 12)

Figure G (Minivelle Figure 12)
FDA Label Image

Trade Carton 0.025mg (Minivelle Figure 13)

Trade Carton 0.025mg (Minivelle Figure 13)
FDA Label Image

Carton 0.0375mg (Minivelle Figure 14)

Carton 0.0375mg (Minivelle Figure 14)
FDA Label Image

Carton 0.05mg (Minivelle Figure 15)

Carton 0.05mg (Minivelle Figure 15)
FDA Label Image

Carton 0.075mg (Minivelle Figure 16)

Carton 0.075mg (Minivelle Figure 16)
Minivelle is a transdermal system that contains 1.24 mg of estradiol USP, which delivers 0.075 mg/day. The system should be applied twice-weekly and contains an acrylic adhesive, silicone adhesive, and other inactive ingredients. It should be stored at 20°C to 25°C and should only be used transdermally. The package should be kept out of children's reach, and applied immediately after removing it from the pouch. Dosage and administration instructions can be found in the package insert. The manufacturer is Noven Pharmaceuticals, Inc. and the distributor is Noven Therapoutics, LLC, both located in Miami, Florida.*
FDA Label Image

Carton 0.1mg (Minivelle Figure 17)

Carton 0.1mg (Minivelle Figure 17)
This appears to be a product description for Minivelle, a transdermal system that delivers 0.1mg/day of estradiol USP. It comes in a package containing 8 systems and is applied twice-weekly. The product contains acrylic and silicone adhesive, oleyl alcohol, dipropylene glycol, among other inactive components. Package should be kept out of reach of children and stored at a controlled room temperature. The manufacturer is Noven Pharmaceuticals, Inc, and the distributor is Noven Therapoutics, LLC from Miami, Florida.*
FDA Label Image

Layers Of Minivelle (Minivelle Figure 2)

Layers Of Minivelle (Minivelle Figure 2)
The product is an adhesive containing estradiol and comes with a protective liner.*
FDA Label Image

Figure 1: Mean Baseline-uncorrected Estradiol Serum Concentration-time Profiles Following A Single Dose Of Minivelle 0.1 mg Per Day (treatment A), 0.05 mg Per Day (treatment B), And 0.025 mg Per Day ( (Minivelle Figure 3)

Figure 1: Mean Baseline-uncorrected Estradiol Serum Concentration-time Profiles Following A Single Dose Of Minivelle 0.1 mg Per Day (treatment A), 0.05 mg Per Day (treatment B), And 0.025 mg Per Day ( (Minivelle Figure 3)
FDA Label Image

Figure 2: Mean (sd) Change From Baseline In Mean Daily Number Of Hot Flushes For Vivelle 0.0375 mg Versus Placebo In A 12 Week Trial. (Minivelle Figure 4)

Figure 2: Mean (sd) Change From Baseline In Mean Daily Number Of Hot Flushes For Vivelle 0.0375 mg Versus Placebo In A 12 Week Trial. (Minivelle Figure 4)
The text describes statistical data of a study conducted over 12 weeks, with measurements taken at weeks 4, 8, and 12. The data includes numeric values for different variables and a comparison between a treatment called Vivelle and a placebo. The last sentence suggests that there was a statistically significant difference between the two treatments.*
FDA Label Image

Figure 3: Bone Mineral Density – Ap Lumbar Spine (Minivelle Figure 5)

Figure 3: Bone Mineral Density – Ap Lumbar Spine (Minivelle Figure 5)
This is a table or graph showing the % change from baseline for different treatments at different time points (Week 2, Week 26, Week 78, and Week 104). The treatments compared include Vivelle 0.1mg/day, Vivelle 0.025mg/day, Vivelle 0.05mg/day, Vivelle 0.0375mg/day, and Placebo.*
FDA Label Image

Figure 4 Bone Mineral Density (Femoral neck)

Figure 4 Bone Mineral Density (Femoral neck)
This text appears to be a table showing the percentage change from baseline for various treatments over the course of several weeks. The treatments are labeled A, B, C, D, and P. There are statistical values listed with some of the treatments, including p-values. The full extent of this data set is not available and any further interpretation of the data is not possible.*
FDA Label Image

Figure A (Minivelle Figure 7)

Figure A (Minivelle Figure 7)
This text is a list of three words "PIPPI", "Calendar", and "Pouch containing patch". It seems to describe a product or products, likely related to organization or storage.*
FDA Label Image

Figure B (Minivelle Figure 8)

Figure B (Minivelle Figure 8)
FDA Label Image

Figure C (Minivelle Figure 9)

Figure C (Minivelle Figure 9)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.